APRE vs AAPL: Which Stock is Better?
Side-by-side comparison of Aprea Therapeutics Inc and Apple Inc in 2026
APRE
Aprea Therapeutics Inc
$0.88
AAPL
Apple Inc
$246.86
Key Metrics Comparison
| Metric | APRE | AAPL | Winner |
|---|---|---|---|
| Market Cap | $6.22M | $3.66T | AAPL |
| P/E Ratio | N/A | 33.11 | AAPL |
| EPS (TTM) | $N/A | $7.45 | AAPL |
| Revenue Growth | -1.0% | 0.1% | AAPL |
| Gross Margin | -1619.1% | 46.9% | AAPL |
Analyze APRE
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APRE or AAPL a better investment?
Comparing APRE and AAPL: Aprea Therapeutics Inc has a market cap of $6.22M while Apple Inc has $3.66T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APRE and AAPL?
APRE (Aprea Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APRE or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APRE or AAPL?
AAPL has higher revenue growth at 0.1% vs -1.0% for APRE.
Which company is more profitable: APRE or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to -1619.1% for APRE.
Which is the larger company: APRE or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.66T compared to $6.22M for APRE.
Should I buy APRE or AAPL in 2026?
Both APRE and AAPL have investment merit. APRE trades at $0.88 while AAPL trades at $246.86. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APRE and AAPL stock?
Key differences: Market Cap ($6.22M vs $3.66T), P/E Ratio (N/A vs 33.1x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (-1619.1% vs 46.9%).